{"id":"https://openalex.org/W2224256853","doi":null,"title":"Psychosomatic disorders in general practice: comparisons of treatment with flupenthixol, diazepam and sulpiride.","display_name":"Psychosomatic disorders in general practice: comparisons of treatment with flupenthixol, diazepam and sulpiride.","publication_year":1985,"publication_date":"1985-01-01","ids":{"openalex":"https://openalex.org/W2224256853","mag":"2224256853","pmid":"https://pubmed.ncbi.nlm.nih.gov/3903789"},"language":"en","primary_location":{"id":"pmid:3903789","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3903789","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmatherapeutica","raw_type":"Clinical Trial"},"parent_works":[],"lineage":["https://openalex.org/W2224256853"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038144306","display_name":"Christina Meyers","orcid":"https://orcid.org/0000-0002-5741-7582","observed_orcids":["https://orcid.org/0000-0002-5741-7582"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Meyers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"C Vranckx","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Vranckx","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5004485999","display_name":"Kjell Elgen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Elgen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"4","issue":"4","first_page":"244","last_page":"50"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11334","display_name":"Psychosomatic Disorders and Their Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11334","display_name":"Psychosomatic Disorders and Their Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12035","display_name":"Pain Management and Placebo Effect","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11282","display_name":"Fibromyalgia and Chronic Fatigue Syndrome Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psychosomatic-disorders","display_name":"psychosomatic disorders","score":0.996999979019165},{"id":"https://openalex.org/keywords/flupenthixol","display_name":"flupenthixol","score":0.9670000076293945},{"id":"https://openalex.org/keywords/diazepam","display_name":"diazepam","score":1.0},{"id":"https://openalex.org/keywords/sulpiride","display_name":"sulpiride","score":1.0},{"id":"https://openalex.org/keywords/psychogenic-headache","display_name":"psychogenic headache","score":0.7990000247955322},{"id":"https://openalex.org/keywords/cardiac-neurosis","display_name":"cardiac neurosis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pruritus","display_name":"pruritus","score":0.9950000047683716},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.7250000238418579},{"id":"https://openalex.org/keywords/benzodiazepines","display_name":"benzodiazepines","score":0.8190000057220459},{"id":"https://openalex.org/keywords/antipsychotic-side-effects","display_name":"antipsychotic adverse effects","score":0.734000027179718},{"id":"https://openalex.org/keywords/general-practice","display_name":"general practice","score":0.6110000014305115}],"concepts":[{"id":"https://openalex.org/C2780806966","wikidata":"https://www.wikidata.org/wiki/Q422418","display_name":"Sulpiride","level":4,"score":0.9371541142463684},{"id":"https://openalex.org/C2776175493","wikidata":"https://www.wikidata.org/wiki/Q210402","display_name":"Diazepam","level":2,"score":0.8880794048309326},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5890851020812988},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4363546371459961},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3677750825881958},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.36499661207199097},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.1721172034740448},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003109","descriptor_name":"Colonic Diseases, Functional","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003975","descriptor_name":"Diazepam","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003975","descriptor_name":"Diazepam","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005475","descriptor_name":"Flupenthixol","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005475","descriptor_name":"Flupenthixol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006261","descriptor_name":"Headache","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009449","descriptor_name":"Neurocirculatory Asthenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011537","descriptor_name":"Pruritus","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011602","descriptor_name":"Psychophysiologic Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011897","descriptor_name":"Random Allocation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013469","descriptor_name":"Sulpiride","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013469","descriptor_name":"Sulpiride","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013892","descriptor_name":"Thioxanthenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:3903789","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3903789","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmatherapeutica","raw_type":"Clinical Trial"},{"id":"mag:2224256853","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3903789","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2410961016","https://openalex.org/W2399300510","https://openalex.org/W2049548914","https://openalex.org/W2203289439","https://openalex.org/W2065087145","https://openalex.org/W2050370226","https://openalex.org/W2116397809","https://openalex.org/W2470944997","https://openalex.org/W2394940014","https://openalex.org/W2099471645"],"abstract_inverted_index":{"One":[0],"hundred":[1],"and":[2,54,65,74,101,158,198],"thirteen":[3],"patients":[4,47,59],"diagnosed":[5],"as":[6],"suffering":[7],"from":[8],"one":[9,49],"of":[10,21,31,51,63,83,94,131,148,154],"four":[11],"common":[12],"psychosomatic":[13],"syndromes":[14],"(psychogenic":[15],"headache,":[16],"cardiac":[17],"neurosis,":[18],"functional":[19],"disturbance":[20],"the":[22,113,145,149,161,165,192],"colon,":[23],"or":[24,36,38,125],"pruritus)":[25],"were":[26,117,169,196],"treated":[27],"by":[28],"two":[29,150,162],"groups":[30],"general":[32],"practitioners":[33],"with":[34,43,55],"flupenthixol":[35,193],"diazepam":[37,44,90],"sulpiride.":[39],"Flupenthixol":[40,77],"was":[41,78,140,156,188],"compared":[42],"in":[45,48,57,60,80,91,109,128,134,144,160,179,182,191,200],"58":[46],"group":[50,62],"Belgian":[52],"practices,":[53],"sulpiride":[56,102],"55":[58],"another":[61],"practices":[64],"assessed":[66],"over":[67],"a":[68,81,88,92,99,107],"4-week":[69],"period":[70],"for":[71],"therapeutic":[72,146],"response":[73],"adverse":[75],"effects.":[76],"given":[79],"dosage":[82,93],"0.5":[84],"to":[85,96,104],"2":[86],"mg":[87,98,106],"day,":[89,108],"2.5":[95],"10":[97,170],"day":[100],"100":[103],"200":[105],"identical":[110],"capsules.":[111],"In":[112,164],"flupenthixol/diazepam":[114],"comparison,":[115,167],"there":[116,139,168],"7":[118],"drop-outs":[119,171],"(3":[120],"flupenthixol,":[121,173],"4":[122],"diazepam).":[123],"Marked":[124],"moderate":[126],"reduction":[127,178],"global":[129],"assessment":[130],"illness":[132],"occurred":[133,181],"both":[135,183,201],"treatment":[136,184],"groups,":[137,185],"but":[138,186],"no":[141],"significant":[142,177],"difference":[143],"effect":[147],"drugs.":[151],"The":[152],"incidence":[153],"side-effects":[155],"low":[157],"similar":[159],"groups.":[163,202],"flupenthixol/sulpiride":[166],"(7":[172],"3":[174],"sulpiride).":[175],"A":[176],"symptoms":[180],"this":[187],"more":[189],"rapid":[190],"group.":[194],"Side-effects":[195],"infrequent":[197],"mild":[199]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}